Clinical trial
Outcome Following Hylan F- 20 (Synvisc) + Corticosteroid Injections for the…
NCT00312533 · Steadman Hawkins Research Foundation, Other · Completed
Key facts
| NCT number | NCT00312533 |
|---|---|
| Title | Outcome Following Hylan F- 20 (Synvisc) + Corticosteroid Injections for the Treatment of Osteoarthritis of the Knee |
| Official title | Outcome Following Hylan F- 20 (Synvisc) + Corticosteroid Injections for the Treatment of Osteoarthritis of the Knee |
| Lead sponsor | Steadman Hawkins Research Foundation, Other |
| Collaborators | Genzyme, a Sanofi Company Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Osteoarthritis, Knee |
| Intervention type | Drug |
| Interventions | Hylan F- 20 |
| Enrollment | 60 |
| Start date | Apr 1, 2006 |
| Primary completion | Feb 1, 2008 |
| Completion | Feb 1, 2008 |
| First posted | Apr 10, 2006 |
| Last update posted | Aug 25, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: